Viz.ai

Viz.ai

Viz.ai is a healthcare startup that uses artificial intelligence to identify early signs of stroke.

Viz.ai is a healthcare startup that uses artificial intelligence to identify early signs of stroke.

Corporate history and product

The company was co-founded by David Golan and Dr. Chris Mansi in 2016, after David suffered a brain malady. Viz.ai, based in San Francisco and Israel, developed the first software for synchronizing healthcare and utilize AI to reduce treatment and intervention time for those suffering from large vessel occlusions (LVOs).

Viz.ai allows doctors and medical professionals to upload CT angiogram images and determine whether there has been a stroke within minutes of photo processing. Once confirmed, an alert is sent to the treating physician and surgical teams. During a stroke, 2 million brain cells die every minute, and strokes are the number one cause of disability in the United States, making timing of intervention critical.

The Viz technology is used in 300 medical facilities across the United States, including those specializing in the treatment of strokes, including The Southeast Regional Stroke Center at Erlanger in University of Tennessee’s Erlanger Medical Center in Chattanooga.

Approvals, Developments, and Partnerships

Viz.ai gained FDA approval, 510(k) in 2018, as the first computer-based triage and notification software. The company’s CT app generating color maps of the brain's blood supply and calculating time plots, has also been approved and made compatible with Viz.ai. The company partnered with Medtronic, the largest medical device company in the world, to accelerate the adoption of Viz.ai’s technology in additional hospitals and reduce treatment time for stroke victims.

Funding and Awards

In July 2018, Viz.ai received $21 million in series A funding.In 2019, the company earned $50 million in series B funding, led by Greenoaks Capital Partners, as well as Alphabet, Charles River Ventures (CRV), Threshold Ventures, GV (formerly Google Ventures), and Kleiner Perkins. The 2019 funding is being used to expand the technology to additional hospitals and the treatment of other diseases. Also in 2019, Viz.ai was named one of Forbe’s AI 50: America’s Most Promising AI Companies.

Timeline

Funding rounds

Funding round
Funding type
Funding round amount (USD)
Funding round date
Investment
Viz.ai funding round, October 2019
Series B round
50,000,000
October 2019
Threshold Ventures
Viz funding round, May 2017
7,500,000
May 2017
DHVC
2 Results
Page 1 of 1
Results per page:
Powered by Golden Research Engine

People

Name
Role
LinkedIn

Further reading

Title
Author
Link
Type
Date

Documentaries, videos and podcasts

Title
Date
Link

Companies

Company
CEO
Location
Products/Services
Golden logo
Text is available under the Creative Commons Attribution-ShareAlike 4.0; additional terms apply. By using this site, you agree to our Terms & Conditions.